Member Spotlight: The American College of Neuropsychopharmacology
By Peter W. Kalivas, PhD, President of the American College of Neuropsychopharmacology. Dr. Kalivas is Professor and Chair, Department of Neurosciences at the Medical University of South Carolina.
The American College of Neuropsychopharmacology (ACNP), founded in 1961, is the nation’s premier professional society in brain, behavior, and neuropharmacology research. The field of neuropsychopharmacology involves evaluating the effects of natural and synthetic compounds upon the brain, mind, and human behavior, and the ACNP serves as a forum for advancing the latest discoveries about the brain towards cures for neuropsychiatric diseases.
The core purpose of the ACNP is to catalyze and advance scientific discovery about disorders of the brain and behavior in order to help prevent, treat and cure brain diseases. The ACNP members are nominated from the national leadership in the fields of Biological Psychiatry and Neuroscience, and the College and its Annual Meeting are kept small by design (just over 1,000 members) in order to facilitate scientific exchange and career mentoring at the Meeting. Importantly, the ACNP is a venue at which the best scientists from academia, government, and industry gather to share, discuss, and debate their research. The College also plays a key role in mentoring early career clinicians and scientists in the field of neuropsychopharmacology via education, travel grants and providing individual mentors.
The ACNP recognizes the critical need to continue to expand our national research effort to acquire basic understanding of how the brain works as a prerequisite for curing brain diseases, and is committed to providing its membership with all avenues that sustain their important explorations into brain physiology and pathology. In this regard, the College is grateful for the unified voice and the partnership that Research!America provides to ensure that investment in research continues to keep pace with the need.